Aripiprazole for Methamphetamine Dependence: Double Blind Placebo Trial
Status:
Withdrawn
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether treatment with Aripiprazole leads to a reduction
in methamphetamine craving and use in patients diagnosed with methamphetamine dependence.
Patients presenting at the Omaha VA Medical Center for treatment of methamphetamine
dependence, and meet inclusion criteria for the study will be invited to participate.
Participation in the study will last for approximately 14 weeks.
Phase:
Phase 4
Details
Lead Sponsor:
US Department of Veterans Affairs VA Office of Research and Development